To Cite:
Thodou
V, Buechter
M, Canbay
A, Baba
H A, Kalsch
J, et al. De-Novo Autoimmune Hepatitis with Consecutive Acute Liver Failure Induced by Hepatitis E Infection: A Case Report,
Hepat Mon.
2017
; 17(3):e40744.
doi: 10.5812/hepatmon.40744.
1.
Hadem J,
Tacke F,
Bruns T,
Langgartner J,
Strnad P,
Denk GU,
et al.
Etiologies and outcomes of acute liver failure in Germany. Clin Gastroenterol Hepatol. 2012; 10(6): 664-9 e2[DOI][PubMed]
2.
Peron JM,
Bureau C,
Poirson H,
Mansuy JM,
Alric L,
Selves J,
et al.
Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat. 2007; 14(5): 298-303[DOI][PubMed]
3.
Streetz KL, Tacke F, Koch A, Trautwein C. [Acute liver failure. Diagnosis and therapy]. Med Klin Intensivmed Notfmed. 2013; 108(8): 639-45[DOI][PubMed]
4.
Rigopoulou EI,
Smyk DS,
Matthews CE,
Billinis C,
Burroughs AK,
Lenzi M,
et al.
Epstein-barr virus as a trigger of autoimmune liver diseases. Adv Virol. 2012; 2012: 987471[DOI][PubMed]
5.
Kaba M, Moal V, Gerolami R, Colson P. Epidemiology of mammalian hepatitis E virus infection. Intervirology. 2013; 56(2): 67-83[DOI][PubMed]
6.
Kamar N,
Bendall R,
Legrand-Abravanel F,
Xia NS,
Ijaz S,
Izopet J,
et al.
Hepatitis E. Lancet. 2012; 379(9835): 2477-88[DOI][PubMed]
7.
Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012; 55(4): 988-97[DOI][PubMed]
8.
Faber MS, Wenzel JJ, Jilg W, Thamm M, Hohle M, Stark K. Hepatitis E virus seroprevalence among adults, Germany. Emerg Infect Dis. 2012; 18(10): 1654-7[DOI][PubMed]
9.
Pischke S,
Hardtke S,
Bode U,
Birkner S,
Chatzikyrkou C,
Kauffmann W,
et al.
Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int. 2013; 33(5): 722-6[DOI][PubMed]
10.
Kamar N,
Izopet J,
Tripon S,
Bismuth M,
Hillaire S,
Dumortier J,
et al.
Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med. 2014; 370(12): 1111-20[DOI][PubMed]
12.
Pischke S, Agisa Witte T, Suneetha PV. Increased HEV seroprevalence in patients with autoimmune hepatitis. J Hepatol . 2013; 508: 409-566
13.
Vieira CL, Baldaia C, Fatela N, Ramalho F, Cardoso C. Case of acute hepatitis E with concomitant signs of autoimmunity. World J Hepatol. 2013; 5(3): 152-5[DOI][PubMed]
14.
Doudier B, Vencatassin H, Aherfi S, Colson P. Fatal fulminant hepatitis E associated with autoimmune hepatitis and excessive paracetamol intake in Southeastern France. J Clin Microbiol. 2014; 52(4): 1294-7[DOI][PubMed]
15.
Pischke S,
Gisa A,
Suneetha PV,
Wiegand SB,
Taubert R,
Schlue J,
et al.
Increased HEV seroprevalence in patients with autoimmune hepatitis. PLoS One. 2014; 9(1)[DOI][PubMed]
16.
Bouamra Y, Benali S, Tissot-Dupont H, Tamalet C, Colson P. Hepatitis B and E co-primary infections in an HIV-1-infected patient. J Clin Microbiol. 2013; 51(3): 1052-6[DOI][PubMed]
17.
Rodriguez Lay Lde L,
Quintana A,
Villalba MC,
Lemos G,
Corredor MB,
Moreno AG,
et al.
Dual infection with hepatitis A and E viruses in outbreaks and in sporadic clinical cases: Cuba 1998-2003. J Med Virol. 2008; 80(5): 798-802[DOI][PubMed]
18.
Gerolami R, Borentain P, Raissouni F, Motte A, Solas C, Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol. 2011; 52(1): 60-2[DOI][PubMed]
19.
Peron JM, Dalton H, Izopet J, Kamar N. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? J Hepatol. 2011; 54(6): 1323-4[DOI][PubMed]
Readers' Comments